| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 7e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 7e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |